Rosiglitazone modifies the adipogenic potential of human muscle satellite cells

Diabetologia

Volumn 49, Issue 8, 2006, Pages 1962-1973

  De Coppi, P ^a   Milan, G ^a   Scarda, A ^a   Boldrin, L ^a   Centobene, C ^a   Piccoli, M ^a   Pozzobon, M ^a   Pilon, C ^a   Pagano, C ^a   Gamba, P ^a   Vettor, R ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Adipocytokines; Adipogenesis; Ectopic fat depot; Insulin resistance; Muscle; Rosiglitazone; Satellite cells

Indexed keywords

INSULIN SENSITIZING AGENT; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; BODY FAT; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE BIOPSY; MUSCLE DEVELOPMENT; MUSCLE FIBER CULTURE; MYOTUBE; NORMAL HUMAN; OSTEOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKELETAL MUSCLE SATELLITE CELL; STROMA CELL; UPREGULATION;

ADIPOGENESIS; ADOLESCENT; ADULT; BIOPSY; CHILD; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MUSCLE FIBERS; MUSCLE, SKELETAL; SATELLITE CELLS, SKELETAL MUSCLE; THIAZOLIDINEDIONES;

EID: 33745774804     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0304-6     Document Type: Article

References (45)

1. Greco AV, Mingrone G, Giancaterini A et al (2002) Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51:144-151
2. Goodpaster BH, Krishnaswami S, Resnick H et al (2003) Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 26:372-379
3. Gallagher D, Kuznia P, Heshka S et al (2005) Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr 81:903-910
4. Cao B, Huard J (2004) Muscle-derived stem cells. Cell Cycle 3:104-107
5. Wagers AJ, Conboy IM (2005) Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122:659-667
6. Shefer G, Wleklinski-Lee M, Yablonka-Reuveni Z (2004) Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway. J Cell Sci 117:5393-5404
7. Asakura A, Komaki M, Rudnicki M (2001) Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68:245-253
8. Teboul L, Gaillard D, Staccini L, Inadera H, Amri EZ, Grimaldi PA (1995) Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J Biol Chem 270:28183-28187
9. Rosen ED, Spiegelman BM (2001) PPARgamma: a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem 276:37731-37734
10. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
11. Tontonoz P, Hu E, Spiegelman BM (1994) Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79:1147-1156
12. Hu E, Tontonoz P, Spiegelman BM (1995) Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc Natl Acad Sci USA 92:9856-9860
13. Tontonoz P, Hu E, Spiegelman BM (1995) Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev 5:571-576
14. Ross SE, Hemati N, Longo KA et al (2000) Inhibition of adipogenesis by Wnt signaling. Science 289:950-953
15. Bennett CN, Ross SE, Longo KA et al (2002) Regulation of Wnt signaling during adipogenesis. J Biol Chem 277:30998-31004
16. Artaza JN, Bhasin S, Magee TR et al (2005) Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multi-potent cells. Endocrinology 146:3547-3557
17. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R (2003) Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 162:1135-1147
18. McPherron AC, Lee SJ (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109:595-601
19. Zimmers TA, Davies MV, Koniaris LG et al (2002) Induction of cachexia in mice by systemically administered myostatin. Science 296:1486-1488
20. Kim HS, Liang L, Dean RG, Hausman DB, Hartzell DL, Baile CA (2001) Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 cultures. Biochem Biophys Res Commun 281:902-906
21. Rosenblatt JD, Lunt AI, Parry DJ, Partridge TA (1995) Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev Biol Anim 31:773-779
22. Bonavaud S, Agbulut O, D'Honneur G, Nizard R, Mouly V, Butler-Browne G (2002) Preparation of isolated human muscle fibers: a technical report. In Vitro Cell Dev Biol Anim 38: 66-72
23. Milan G, Dalla Nora E, Pilon C et al (2004) Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab 89:2724-2727
24. Bosch P, Musgrave DS, Lee JY et al (2000) Osteoprogenitor cells within skeletal muscle. J Orthop Res 18:933-944
25. Rochat A, Fernandez A, Vandromme M et al (2004) Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy. Mol Biol Cell 15: 4544-4555
26. Muscat GE, Mynett-Johnson L, Dowhan D, Downes M, Griggs R (1994) Activation of myoD gene transcription by 3,5,3′-triiodo-L-thyronine: a direct role for the thyroid hormone and retinoid X receptors. Nucleic Acids Res 22:583-591
27. Park KS, Ciaraldi TP, Lindgren K et al (1998) Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma. J Clin Endocrinol Metab 83:2830-2835
28. Kausch C, Krutzfeldt J, Witke A et al (2001) Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells. Biochem Biophys Res Commun 280:664-674
29. Rosen ED, Sarraf P, Troy AE et al (1999) PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611-617
30. Kallen CB, Lazar MA (1996) Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 93:5793-5796
31. Patel NG, Holder JC, Smith SA, Kumar S, Eggo MC (2003) Differential regulation of lipogenesis and leptin production by independent signaling pathways and rosiglitazone during human adipocyte differentiation. Diabetes 52:43-50
32. Fukuhara A, Matsuda M, Nishizawa M et al (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307:426-430
33. Berndt J, Kloting N, Kralisch S et al (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54:2911-2916
34. Steppan CM, Bailey ST, Bhat S et al (2001) The hormone resistin links obesity to diabetes. Nature 409:307-312
35. Choi KC, Ryu OH, Lee KW et al (2005) Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Biochem Biophys Res Commun 336:747-753
36. Nagaev I, Smith U (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285: 561-564
37. Savage DB, Sewter CP, Klenk ES et al (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50: 2199-2202
38. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM (2002) Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res 10:1-5
39. Cossu G, Borello U (1999) Wnt signaling and the activation of myogenesis in mammals. Embo J 18:6867-6872
40. Ridgeway AG, Petropoulos H, Wilton S, Skerjanc IS (2000) Wnt signaling regulates the function of MyoD and myogenin. J Biol Chem 275:32398-32405
41. Taylor-Jones JM, McGehee RE, Rando TA, Lecka-Czernik B, Lipschitz DA, Peterson CA (2002) Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev 123: 649-661
42. Christodoulides C, Scarda A, Granzotto M et al (2006) WNT10B mutations in human obesity. Diabetologia 49:678-684
43. Vertino AM, Taylor-Jones JM, Longo KA et al (2005) Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol Biol Cell 16:2039-2048
44. Kirkland JL, Tchkonia T, Pirtskhalava T, Han J, Karagiannides I (2002) Adipogenesis and aging: does aging make fat go MAD? Exp Gerontol 37:757-767
45. Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR (2005) Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists. Am J Physiol Endocrinol Metab 289:E151-E159